<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38903385</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Cardiac Damage After SARS-CoV2 Infection.</ArticleTitle><Pagination><StartPage>e60641</StartPage><MedlinePgn>e60641</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e60641</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.60641</ELocationID><Abstract><AbstractText>COVID-19 is a viral disease that can manifest acutely in the respiratory tract and other organs. In this study, we aimed to investigate potential long-term damage to the heart from COVID-19. For this study, we divided 97 consecutive unselected COVID-19 patients aged 18-80 years at a cardiology practice in Cologne, Germany, into two groups based on the severity of their infection. We performed a resting ECG and a resting transthoracic echocardiography three and six months after SARS-CoV2 infection. The key discriminator determining disease severity was bed confinement or hospital admission. Group 1 included patients with less severe COVID-19, whereas group 2 contained more severe cases. Heart rate as the primary ECG endpoint was lower by a statistically significant amount for the entire study population (p=0.024), subdivided by gender (p<sub>women</sub> &lt;0.001, p<sub>men</sub> &lt;0.001) and in group 1 p =0.003&#xa0;compared to three months. QTc time and repolarization disturbances as primary ECG endpoints and the echocardiographic primary endpoints, left ventricular ejection fraction, and left ventricular end-diastolic diameter (LVEDD), showed no relevant difference between the subgroups at three and six months or between the measurements taken at each point. In contrast, LVEDD normalized to body surface area was statistically significantly lower at six months in women in group 1 compared to group 2 (p=0.048) and in the overall study population at six months compared with the data after three months (p=0.034). E/E' was statistically lower at six months than at three months in the whole population (p=0.004) and in women (p=0.031). All measured echocardiographic and electrocardiographic mean values were within the normal range in all groups and follow-up controls. Overall, the prospective study conducted showed no significant evidence of long-term cardiac damage from COVID-19 disease, as evidenced by electrocardiographic and echocardiographic examinations at three and six months after infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Bohlen et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bohlen</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cardiology, Medizinisches Versorgungszentrum (MVZ) Franzen Institut, Cologne, DEU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franzen</LastName><ForeName>Damian</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology, Medizinisches Versorgungszentrum (MVZ) Franzen Institut, Cologne, DEU.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2-dimensional echocardiography</Keyword><Keyword MajorTopicYN="N">cardiac risk factors and prevention</Keyword><Keyword MajorTopicYN="N">corona virus</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">covid-19 long term outcomes</Keyword><Keyword MajorTopicYN="N">electrocardiography (ecg)</Keyword><Keyword MajorTopicYN="N">long covid syndrome</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38903385</ArticleId><ArticleId IdType="pmc">PMC11187443</ArticleId><ArticleId IdType="doi">10.7759/cureus.60641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A novel coronavirus from patients with pneumonia in China, 2019. Zhu N, Zhang D, Wang W, et al. N Engl J Med. 2020;382:727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO declares COVID-19 a pandemic. Cucinotta D, Vanelli M. Acta Biomed. 2020;91:157&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Huang C, Wang Y, Li X, et al. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Guzik TJ, Mohiddin SA, Dimarco A, et al. Cardiovasc Res. 2020;116:1666&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. JACC Basic Transl Sci. 2020;5:518&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151394</ArticleId><ArticleId IdType="pubmed">32292848</ArticleId></ArticleIdList></Reference><Reference><Citation>Extrapulmonary manifestations of COVID-19. Gupta A, Madhavan MV, Sehgal K, et al. Nat Med. 2020;26:1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis of acute pericarditis. Xanthopoulos A, Skoularigis J. https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-15/Diagnosis-of-acute-pericarditis E Soc Cardiol. 2017;15:15.</Citation></Reference><Reference><Citation>COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Mitrani RD, Dabas N, Goldberger JJ. Heart Rhythm. 2020;17:1984&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Trappe H, Schuster H. Hrsg. Vol. 7. Stuttgart: Thieme; 2017. EKG-Kurs f&#xfc;r Isabel (Book in German)</Citation></Reference><Reference><Citation>GE Healthcare User Manual: Auto-EF. Chapter: Auto-EF. 2024.</Citation></Reference><Reference><Citation>Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Lang RM, Badano LP, Mor-Avi V, et al. Eur Heart J Cardiovasc Imaging. 2015;16:233&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">25712077</ArticleId></ArticleIdList></Reference><Reference><Citation>Does COVID-19 cause hypertension? Akpek M. Angiology. 2022;73:682&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9260192</ArticleId><ArticleId IdType="pubmed">34889662</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and arrhythmia: an overview. Varney JA, Dong VS, Tsao T, et al. J Cardiol. 2022;79:468&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632592</ArticleId><ArticleId IdType="pubmed">35074257</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrhythmias and COVID-19: a review. Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, Tedrow U. JACC Clin Electrophysiol. 2020;6:1193&#x2013;1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417167</ArticleId><ArticleId IdType="pubmed">32972561</ArticleId></ArticleIdList></Reference><Reference><Citation>Electrocardiographic manifestations of COVID-19. Long B, Brady WJ, Bridwell RE, Ramzy M, Montrief T, Singh M, Gottlieb M. Am J Emerg Med. 2021;41:96&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771377</ArticleId><ArticleId IdType="pubmed">33412365</ArticleId></ArticleIdList></Reference><Reference><Citation>Right bundle branch block: prevalence, incidence, and cardiovascular morbidity and mortality in the general population. Alventosa-Zaidin M, Guix Font L, Benitez Camps M, et al. Eur J Gen Pract. 2019;25:109&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713172</ArticleId><ArticleId IdType="pubmed">31339387</ArticleId></ArticleIdList></Reference><Reference><Citation>Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Bussink BE, Holst AG, Jespersen L, Deckers JW, Jensen GB, Prescott E. Eur Heart J. 2013;34:138&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">22947613</ArticleId></ArticleIdList></Reference><Reference><Citation>Incomplete right bundle branch block: a novel electrocardiographic marker for lone atrial fibrillation. Nielsen JB, Olesen MS, Tang&#xf8; M, Hauns&#xf8; S, Holst AG, Svendsen JH. Europace. 2011;13:182&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">21138928</ArticleId></ArticleIdList></Reference><Reference><Citation>Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. Mason JW, Ramseth DJ, Chanter DO, Moon TE, Goodman DB, Mendzelevski B. J Electrocardiol. 2007;40:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">17276451</ArticleId></ArticleIdList></Reference><Reference><Citation>Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Szekely Y, Lichter Y, Taieb P, et al. Circulation. 2020;142:342&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Visual versus fully automated assessment of left ventricular ejection fraction. Abazid RM, Abohamr SI, Smettei OA, et al. Avicenna J Med. 2018;8:41&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5898181</ArticleId><ArticleId IdType="pubmed">29682476</ArticleId></ArticleIdList></Reference><Reference><Citation>Association between COVID-19 and myocarditis using hospital-based administrative data - United States, March 2020-January 2021. Boehmer TK, Kompaniyets L, Lavery AM, et al.  http://dx.doi.org/10.15585/mmwr.mm7035e5. MMWR Morb Mortal Wkly Rep. 2021;70:1228&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422872</ArticleId><ArticleId IdType="pubmed">34473684</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiac performance in patients hospitalized with COVID-19: a 6&#xa0;month follow-up study. Fayol A, Livrozet M, Boutouyrie P, et al. ESC Heart Fail. 2021;8:2232&#x2013;2239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120370</ArticleId><ArticleId IdType="pubmed">33773099</ArticleId></ArticleIdList></Reference><Reference><Citation>Myocarditis associated with COVID-19 disease: a systematic review of published case reports and case series. Rathore SS, Rojas GA, Sondhi M, et al. Int J Clin Pract. 2021;75:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">34235815</ArticleId></ArticleIdList></Reference><Reference><Citation>H(2) FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors. Suzuki S, Kaikita K, Yamamoto E, et al. ESC Heart Fail. 2020;7:65&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083475</ArticleId><ArticleId IdType="pubmed">31967406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>